Floatz logo

1-(4,4-BIS(P-FLUOROPHENYL)BUTYL)-4-(4-CHLORO-.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)-4-PIPERIDINOL

Small Cell Cervical Carcinoma

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologySmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Small Cell Cervical Carcinoma cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
Uganda Cancer Institute
Phase 2BB
Hycamtin
National Cancer Institute (NCI)
Phase 2B
Veliparib
National Cancer Institute (NCI)
Phase 2B
PEGFILGRASTIM
National Cancer Institute (NCI)
Phase 2B
FILGRASTIM
National Cancer Institute (NCI)
Phase 2B
FERUMOXTRAN 10
National Cancer Institute (NCI)
Phase 1/2CCC
Cetuximab
Gynecologic Oncology Group
Phase 1CC
Axalimogene Filolisbac
Advaxis, Inc.
Phase 1CC

Same molecule, other indications

1-(4,4-BIS(P-FLUOROPHENYL)BUTYL)-4-(4-CHLORO-.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)-4-PIPERIDINOL is also rated in:

small cell lung carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
small cell carcinomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →